Repros Therapeutics (RPRX) Tops Q3 EPS by 7c
Get Alerts RPRX Hot Sheet
Price: $28.11 +0.46%
Revenue Growth %: -2.1%
Financial Fact:
Interest income: 10K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: -2.1%
Financial Fact:
Interest income: 10K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q3 EPS of ($0.32), $0.07 better than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Seacoast Banking Corporation of Florida (SBCF) Tops Q1 EPS by 2c
- Agnico Eagle Mines (AEM) Tops Q1 EPS by 17c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!